Francesca Broso

6PUBLICATIONS
54CO-AUTHORS
Medical infection agents (incl. prions)Neurology and neuromuscular diseasesMolecular targetsMedical bacteriologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 16, 2024
The three YTHDF paralogs and VIRMA are strong cross-histotype tumor driver candidates among m6A core genes.

Eliana Destefanis, Denise Sighel, Davide Dalfovo

|May 15, 2024
Striatin knock out induces a gain of function of INa and impaired Ca2+ handling in mESC-derived cardiomyocytes.

P Benzoni, M Arici, F Giannetti

|May 11, 2024
EGCG Disrupts the LIN28B/Let-7 Interaction and Reduces Neuroblastoma Aggressiveness.

Simona Cocchi, Valentina Greco, Viktoryia Sidarovich

|Feb 05, 2024
Sterile inflammation via TRPM8 RNA-dependent TLR3-NF-kB/IRF3 activation promotes antitumor immunity in prostate cancer.

Alessandro Alaimo, Sacha Genovesi, Nicole Annesi

|Jun 08, 2023
Alpha-1 Adrenergic Antagonists Sensitize Neuroblastoma to Therapeutic Differentiation.

Francesca Broso, Pamela Gatto, Viktoryia Sidarovich

|Sep 27, 2022
Translational enhancement by base editing of the Kozak sequence rescues haploinsufficiency.

Chiara Ambrosini, Eliana Destefanis, Eyemen Kheir

Pageof 1